An oral apolipoprotein A-I mimetic peptide, D-4F, converts monkey HDL to anti-inflammatory

被引：0
|
作者：
Bachini, EA [1 ]
Hama, S [1 ]
Yu, N [1 ]
Chyu, C [1 ]
Hough, G [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1055 / A1055
页数：1
相关论文
共 50 条
  • [41] The apolipoprotein A-I mimetic peptide, D-4F, alleviates ox-LDL-induced oxidative stress and promotes endothelial repair through the eNOS/HO-1 pathway
    Liu, Donghui
    Ding, Zhenzhen
    Wu, Mengzhang
    Xu, Wenqi
    Qian, Mingming
    Du, Qian
    Zhang, Le
    Cui, Ye
    Zheng, Jianlan
    Chang, He
    Huang, Caihua
    Lin, Donghai
    Wang, Yan
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 105 : 77 - 88
  • [42] Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides
    Gomaraschi, Monica
    Calabresi, Laura
    Rossoni, Giuseppe
    Iametti, Stefania
    Franceschini, Guido
    Stonik, John A.
    Remaley, Alan T.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (02): : 776 - 783
  • [43] An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide
    Wool, Geoffrey D.
    Vaisar, Tomas
    Reardon, Catherine A.
    Getz, Godfrey S.
    JOURNAL OF LIPID RESEARCH, 2009, 50 (09) : 1889 - 1900
  • [44] The apolipoprotein A-1 mimetic peptide D-4F acts as a scavenger for myeloperoxiclase-derived hypochlorous acid
    Wake, Amanda
    Datta, Geeta
    Mahtani, Harry
    PaIgunachari, Mayakonda
    Parks, Dale
    Mishra, Vinod
    Anantharamaiah, Gm
    White, C. Roger
    CIRCULATION, 2007, 116 (16) : 27 - 27
  • [45] D-4F, an apolipoprotein A-I mimetic, suppresses IL-4 induced macrophage alternative activation and pro-fibrotic TGF-β1 expression
    Song, Xuejiao
    Shi, Ying
    You, Jia
    Wang, Zhengshu
    Xie, Linshen
    Zhang, Chaoxiong
    Xiong, Jingyuan
    PHARMACEUTICAL BIOLOGY, 2019, 57 (01) : 470 - 476
  • [46] Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
    Bloedon, LeAnne T.
    Dunbar, Richard
    Duffy, Danielle
    Pinell-Salles, Paula
    Norris, Robert
    DeGroot, Bruce J.
    Movva, Rajesh
    Navab, Mohamad
    Fogelman, Alan M.
    Rader, Daniel J.
    JOURNAL OF LIPID RESEARCH, 2008, 49 (06) : 1344 - 1352
  • [47] Potential restoration of HDL function with apolipoprotein A-I mimetic peptide in end-stage renal disease
    Kaysen, George A.
    KIDNEY INTERNATIONAL, 2009, 76 (04) : 359 - 361
  • [48] Addition of nanomolar concentrations of D-4F to human plasma in vitro causes the movement of ApoA-I to smaller particles, reduces lipid hydroperoxides, increases paraoxonase activity, and converts proinflammatory HDL to anti-inflammatory
    Yu, N
    Navab, M
    Anantharamaiah, GM
    Chyu, C
    Hama, S
    Hough, GP
    Reddy, ST
    Garber, DW
    Palgunachari, MN
    Fogelman, AM
    CIRCULATION, 2004, 110 (17) : 243 - 243
  • [49] Synthetic apolipoprotein A-I mimetic peptide 4F protects hearts and kidneys after myocardial infarction
    Moreira, Roberto S.
    Irigoyen, Maria C.
    Capcha, Jose M. C.
    Sanches, Talita R.
    Gutierrez, Paulo S.
    Garnica, Margoth R.
    Noronha, Irene de L.
    Andrade, Lucia
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY, INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2020, 318 (03) : R529 - R544
  • [50] Apolipoprotein A-I Mimetic Peptide L-4F Prevents Myocardial and Coronary Dysfunction in Diabetic Mice
    Vecoli, C.
    Cao, J.
    Neglia, D.
    Inoue, K.
    Sodhi, K.
    Vanella, L.
    Gabrielson, K. K.
    Bedja, D.
    Paolocci, N.
    L'Abbate, A.
    Abraham, N. G.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (09) : 2616 - 2626
12345